Clinical Accelerator Leadership

Jedd D. Wolchok, M.D., Ph.D.

Memorial Sloan Kettering Cancer Center

Nina Bhardwaj, M.D., Ph.D.

Icahn School of Medicine at Mount Sinai

Julie R. Brahmer, M.D.

Johns Hopkins

George Coukos, M.D., Ph.D.

Ludwig Cancer Research and University Hospitals of Canton Vaud (CHUV)

Lawrence Fong, M.D.

University of California, San Francisco

F. Stephen Hodi, M.D.

Dana-Farber Cancer Institute

Dirk Jaeger, M.D.

National Center for Tumor Diseases Heidelberg

Elizabeth M. Jaffee, M.D.

Johns Hopkins University School of Medicine

Carl H. June, M.D.

University of Pennsylvania School of Medicine

Kunle Odunsi, M.D., Ph.D.

The University of Chicago

Antoni Ribas, M.D., Ph.D.

University of California, Los Angeles Comprehensive Cancer Center

Michel Sadelain, M.D., Ph.D.

Memorial Sloan Kettering Cancer Center

Neil H. Segal, M.D., Ph.D.

Memorial Sloan Kettering Cancer Center

Padmanee Sharma, M.D., Ph.D.

The University of Texas MD Anderson Cancer Center

Craig L. Slingluff Jr., M.D.

University of Virginia Health System

Pramod K. Srivastava, M.D., Ph.D.

University of Connecticut School of Medicine

Marcel van den Brink, M.D., Ph.D.

Memorial Sloan Kettering Cancer Center

Robert H. Vonderheide, M.D., D.Phil.

University of Pennsylvania

E. John Wherry, Ph.D.

University of Pennsylvania School of Medicine

Cassian Yee, M.D.

The University of Texas MD Anderson Cancer Center

Jill O'Donnell-Tormey, Ph.D.

Chief Executive Officer and Director of Scientific Affairs

Jay Campbell

Managing Director, CRI Clinical Accelerator and Venture Fund

Ana Rosa Sáez Ibáñez, Ph.D.

Research Analyst, Clinical Accelerator and Venture Fund

Samik Upadhaya, Ph.D.

Assistant Director, Scientific Affairs